Barriers to colorectal cancer screening among Medicare consumers

American Journal of Preventive Medicine
Carrie N KlabundeWilliam W Davis

Abstract

Few studies have examined lack of physician recommendation and other reasons for under-utilization of colorectal cancer (CRC) screening in the Medicare population. Data from a telephone survey conducted in 2001 in a random sample of Medicare consumers residing in North and South Carolina were used to examine barriers to CRC screening, focusing on consumers' reports of receiving a physician's recommendation to obtain CRC screening and reasons for not being screened. Analyses were restricted to respondents with no history of CRC (n = 1901). Descriptive statistics were used to characterize respondents' CRC screening status, receipt of a physician's recommendation for screening, and reasons for not being screened. Logistic regression modeling was used to examine factors associated with receiving a physician recommendation for fecal occult blood test, sigmoidoscopy, colonoscopy, any endoscopy, and any CRC test. Thirty-one percent of Medicare consumers had never been tested for CRC, and 18% had been tested but were not current with Medicare-covered intervals. Overall, 28% reported not receiving a physician recommendation for screening. Predictors of receiving a physician recommendation included sociodemographic (younger age, white ra...Continue Reading

Associated Clinical Trials

References

Apr 7, 1993·Journal of the National Cancer Institute·N P GordonD I Lampert
Sep 1, 1996·Journal of General Internal Medicine·S F Lewis, N M Jensen
Oct 6, 2000·American Journal of Preventive Medicine·M T MandelsonA Z LaCroix
Dec 3, 2002·Archives of Internal Medicine·Cynthia W KoLaura-Mae Baldwin
Dec 23, 2003·Expert Review of Anticancer Therapy·Angel Ferrández, James A DiSario
Sep 8, 2004·Cancer Detection and Prevention·P BrawarskyP A Wood

❮ Previous
Next ❯

Citations

Dec 19, 2007·Cancer Causes & Control : CCC·Hind A Beydoun, May A Beydoun
Oct 6, 2011·Cancer Causes & Control : CCC·Maria Y HoWinson Y Cheung
Dec 15, 2007·Journal of Community Health·Paul C SchroyKaren M Emmons
Sep 15, 2012·Journal of Community Health·Benjamin W QuickK Allen Greiner
Mar 20, 2008·Journal of General Internal Medicine·Alexander R GreenSteven J Atlas
Feb 15, 2013·Population Health Management·Rohan MahabaleshwarkarYi Yang
Feb 11, 2010·Cancer Nursing·Suha Omran, Ahmad Abedalkareem Ismail
Mar 23, 2007·Journal of Gastroenterology and Hepatology·Raanan ShamirRami Eliakim
Feb 5, 2009·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Joshua J FentonPeter Franks
Oct 7, 2011·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·K Robin YabroffStephen H Taplin
Jul 30, 2011·Hereditary Cancer in Clinical Practice·Erika M SantosBenedito M Rossi
Jan 14, 2009·Annals of Family Medicine·Roberto Cardarelli, Jennifer E Thomas
Aug 25, 2009·World Journal of Gastroenterology : WJG·Wen MengSu-Zhan Zhang
Mar 14, 2013·World Journal of Gastroenterology : WJG·Alexandra ModiriFrank Friedenberg
May 15, 2010·American Journal of Health Promotion : AJHP·Carol BallewJoanne Oreskovich
Jun 20, 2014·BMC Cancer·Cam EscofferyRegine Haardörfer
May 17, 2014·American Journal of Public Health·Ramin AsgaryBlanca Sckell
Feb 19, 2014·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Gene K Ma, Uri Ladabaum
Oct 16, 2010·Journal of General Internal Medicine·K Robin YabroffStephen Taplin
Dec 26, 2015·International Journal of Environmental Research and Public Health·Christine Miranda-DiazRobert F Hunter-Mellado
Dec 19, 2015·Oncology Nursing Forum·JoAnn S OliverSandra Ford
Apr 2, 2013·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Tuan DinhTheodore R Levin
Jun 18, 2011·Preventive Medicine·Shayna E RichEileen K Steinberger
Sep 14, 2010·Best Practice & Research. Clinical Gastroenterology·Carlo SenorePaola Armaroli
Dec 17, 2009·Preventive Medicine·Idris GuessousUNKNOWN National Colorectal Cancer Roundtable Screening Among the 65 Plus Task Group
Jun 30, 2009·Gastrointestinal Endoscopy·Colleen M Schmitt
Aug 30, 2008·Journal of the American College of Radiology : JACR·Ania Z Kielar, Robert H El-Maraghi
Sep 17, 2013·Cancer·Terry DavisMichael Wolf
Mar 29, 2014·Journal of Cancer Education : the Official Journal of the American Association for Cancer Education·Jeanette M DalyBarcey T Levy
Jul 9, 2013·Journal of Cancer Education : the Official Journal of the American Association for Cancer Education·Carrie R WongLina Jandorf
Jan 5, 2014·Journal of Cancer Education : the Official Journal of the American Association for Cancer Education·Danielle M CrookesLina Jandorf

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.